Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 183

1.

Osteonecrosis in children with acute lymphoblastic leukemia at initial diagnosis and prior to any chemotherapy.

Krull K, Kunstreich M, Bronsema A, Bleckmann K, Classen CF, Erdlenbruch B, Jorch N, Kolb R, Leipold A, Moser O, Prokop A, Scheurlen W, Steinbach D, Klasen-Sansone J, Klee D, Escherich G, Moericke A, Schrappe M, Borkhardt A, Kuhlen M.

Leuk Lymphoma. 2018 May 2:1-7. doi: 10.1080/10428194.2018.1466292. [Epub ahead of print]

PMID:
29718744
2.

Neurotoxic side effects in children with refractory or relapsed T-cell malignancies treated with nelarabine based therapy.

Kuhlen M, Bleckmann K, Möricke A, Schrappe M, Vieth S, Escherich G, Bronsema A, Vonalt A, Queudeville M, Zwaan CM, Ebinger M, Debatin KM, Klingebiel T, Koscielniak E, Rossig C, Burkhardt B, Kolb R, Eckert C, Borkhardt A, von Stackelberg A, Chen-Santel C.

Br J Haematol. 2017 Oct;179(2):272-283. doi: 10.1111/bjh.14877. Epub 2017 Aug 2.

PMID:
28771662
3.

Use of intraoperative local field potential spectral analysis to differentiate basal ganglia structures in Parkinson's disease patients.

Kolb R, Abosch A, Felsen G, Thompson JA.

Physiol Rep. 2017 Jun;5(12). pii: e13322. doi: 10.14814/phy2.13322.

4.

Osteonecrosis develops independently from radiological leukemic infiltration of bone in adolescents with acute lymphoblastic leukemia - first findings of the OPAL trial.

Krull K, Kunstreich M, Klasen-Sansone J, Kloetgen A, Gruener F, Escherich G, Bleckmann K, Moericke A, Schrappe M, Jorch N, Steinbach D, Classen CF, Guggemos A, Kolb R, Klee D, Borkhardt A, Kuhlen M.

Leuk Lymphoma. 2017 Oct;58(10):2363-2369. doi: 10.1080/10428194.2017.1280605. Epub 2017 Jan 31.

PMID:
28140726
5.

Metabolic Patterns in Chronic Multiple Sclerosis Lesions and Normal-appearing White Matter: Intraindividual Comparison by Using 2D MR Spectroscopic Imaging.

Fleischer V, Kolb R, Groppa S, Zipp F, Klose U, Gröger A.

Radiology. 2016 Nov;281(2):536-543. Epub 2016 May 30.

PMID:
27243371
6.

Obesity-associated NLRC4 inflammasome activation drives breast cancer progression.

Kolb R, Phan L, Borcherding N, Liu Y, Yuan F, Janowski AM, Xie Q, Markan KR, Li W, Potthoff MJ, Fuentes-Mattei E, Ellies LG, Knudson CM, Lee MH, Yeung SJ, Cassel SL, Sutterwala FS, Zhang W.

Nat Commun. 2016 Oct 6;7:13007. doi: 10.1038/ncomms13007.

7.

Involvement of the NLRC4-Inflammasome in Diabetic Nephropathy.

Yuan F, Kolb R, Pandey G, Li W, Sun L, Liu F, Sutterwala FS, Liu Y, Zhang W.

PLoS One. 2016 Oct 5;11(10):e0164135. doi: 10.1371/journal.pone.0164135. eCollection 2016.

8.

Obesity and cancer: inflammation bridges the two.

Kolb R, Sutterwala FS, Zhang W.

Curr Opin Pharmacol. 2016 Aug;29:77-89. doi: 10.1016/j.coph.2016.07.005. Epub 2016 Jul 16. Review.

9.

Leaf epidermis images for robust identification of plants.

da Silva NR, Oliveira MW, Filho HA, Pinheiro LF, Rossatto DR, Kolb RM, Bruno OM.

Sci Rep. 2016 May 24;6:25994. doi: 10.1038/srep25994.

10.

Transcriptome analysis of basal and luminal tumor-initiating cells in ErbB2-driven breast cancer.

Borcherding N, Bormann N, Kusner D, Kolb R, Zhang W.

Genom Data. 2015 Jun 1;4:119-122.

11.

Plant Identification Based on Leaf Midrib Cross-Section Images Using Fractal Descriptors.

da Silva NR, Florindo JB, Gómez MC, Rossatto DR, Kolb RM, Bruno OM.

PLoS One. 2015 Jun 19;10(6):e0130014. doi: 10.1371/journal.pone.0130014. eCollection 2015.

12.

Malignancy-associated haemophagocytic lymphohistiocytosis in children and adolescents.

Lehmberg K, Sprekels B, Nichols KE, Woessmann W, Müller I, Suttorp M, Bernig T, Beutel K, Bode SF, Kentouche K, Kolb R, Längler A, Minkov M, Schilling FH, Schmid I, Vieth S, Ehl S, Zur Stadt U, Janka GE.

Br J Haematol. 2015 Aug;170(4):539-49. doi: 10.1111/bjh.13462. Epub 2015 May 4.

PMID:
25940575
13.

Paracrine WNT5A Signaling Inhibits Expansion of Tumor-Initiating Cells.

Borcherding N, Kusner D, Kolb R, Xie Q, Li W, Yuan F, Velez G, Askeland R, Weigel RJ, Zhang W.

Cancer Res. 2015 May 15;75(10):1972-82. doi: 10.1158/0008-5472.CAN-14-2761. Epub 2015 Mar 13.

14.

Characterization of a novel mouse model with genetic deletion of CD177.

Xie Q, Klesney-Tait J, Keck K, Parlet C, Borcherding N, Kolb R, Li W, Tygrett L, Waldschmidt T, Olivier A, Chen S, Liu GH, Li X, Zhang W.

Protein Cell. 2015 Feb;6(2):117-26. doi: 10.1007/s13238-014-0109-1. Epub 2014 Oct 31.

15.

In vivo proton magnetic resonance spectroscopic imaging of the healthy human brain at 9.4 T: initial experience.

Chadzynski GL, Pohmann R, Shajan G, Kolb R, Bisdas S, Klose U, Scheffler K.

MAGMA. 2015 Jun;28(3):239-49. doi: 10.1007/s10334-014-0460-5. Epub 2014 Sep 24.

PMID:
25248946
16.

A novel function of HER2/Neu in the activation of G2/M checkpoint in response to γ-irradiation.

Yan Y, Hein AL, Greer PM, Wang Z, Kolb RH, Batra SK, Cowan KH.

Oncogene. 2015 Apr 23;34(17):2215-26. doi: 10.1038/onc.2014.167. Epub 2014 Jun 9.

17.

Inflammasomes in cancer: a double-edged sword.

Kolb R, Liu GH, Janowski AM, Sutterwala FS, Zhang W.

Protein Cell. 2014 Jan;5(1):12-20. doi: 10.1007/s13238-013-0001-4. Epub 2014 Jan 29. Review.

18.

Dopamine reduction in the substantia nigra of Parkinson's disease patients confirmed by in vivo magnetic resonance spectroscopic imaging.

Gröger A, Kolb R, Schäfer R, Klose U.

PLoS One. 2014 Jan 8;9(1):e84081. doi: 10.1371/journal.pone.0084081. eCollection 2014.

19.

Beneficial and Detrimental Roles of NLRs in Carcinogenesis.

Janowski AM, Kolb R, Zhang W, Sutterwala FS.

Front Immunol. 2013 Nov 12;4:370. doi: 10.3389/fimmu.2013.00370. eCollection 2013. Review.

20.

β-Sultams exhibit discrete binding preferences for diverse bacterial enzymes with nucleophilic residues.

Kolb R, Bach NC, Sieber SA.

Chem Commun (Camb). 2014 Jan 14;50(4):427-9. doi: 10.1039/c3cc46002a.

PMID:
24251314
21.
22.

Disruption of oligomerization and dehydroalanine formation as mechanisms for ClpP protease inhibition.

Gersch M, Kolb R, Alte F, Groll M, Sieber SA.

J Am Chem Soc. 2014 Jan 29;136(4):1360-6. doi: 10.1021/ja4082793. Epub 2013 Oct 24.

PMID:
24106749
23.

X-linked inhibitor of apoptosis (XIAP) deficiency: the spectrum of presenting manifestations beyond hemophagocytic lymphohistiocytosis.

Speckmann C, Lehmberg K, Albert MH, Damgaard RB, Fritsch M, Gyrd-Hansen M, Rensing-Ehl A, Vraetz T, Grimbacher B, Salzer U, Fuchs I, Ufheil H, Belohradsky BH, Hassan A, Cale CM, Elawad M, Strahm B, Schibli S, Lauten M, Kohl M, Meerpohl JJ, Rodeck B, Kolb R, Eberl W, Soerensen J, von Bernuth H, Lorenz M, Schwarz K, Zur Stadt U, Ehl S.

Clin Immunol. 2013 Oct;149(1):133-41. doi: 10.1016/j.clim.2013.07.004. Epub 2013 Jul 31.

PMID:
23973892
24.

ERK1/2 signaling plays an important role in topoisomerase II poison-induced G2/M checkpoint activation.

Kolb RH, Greer PM, Cao PT, Cowan KH, Yan Y.

PLoS One. 2012;7(11):e50281. doi: 10.1371/journal.pone.0050281. Epub 2012 Nov 16.

25.

RAC1 GTPase plays an important role in γ-irradiation induced G2/M checkpoint activation.

Yan Y, Greer PM, Cao PT, Kolb RH, Cowan KH.

Breast Cancer Res. 2012 Apr 11;14(2):R60.

26.

Collecting duct cells that lack normal cilia have mislocalized vasopressin-2 receptors.

Saigusa T, Reichert R, Guare J, Siroky BJ, Gooz M, Steele S, Fenton RA, Bell PD, Kolb RJ.

Am J Physiol Renal Physiol. 2012 Apr 1;302(7):F801-8. doi: 10.1152/ajprenal.00253.2011. Epub 2011 Dec 28.

27.

Tailoring of integrin ligands: probing the charge capability of the metal ion-dependent adhesion site.

Bollinger M, Manzenrieder F, Kolb R, Bochen A, Neubauer S, Marinelli L, Limongelli V, Novellino E, Moessmer G, Pell R, Lindner W, Fanous J, Hoffman A, Kessler H.

J Med Chem. 2012 Jan 26;55(2):871-82. doi: 10.1021/jm2013826. Epub 2012 Jan 9.

PMID:
22185640
28.

Use of an Internet portal to improve community-based pediatric ADHD care: a cluster randomized trial.

Epstein JN, Langberg JM, Lichtenstein PK, Kolb R, Altaye M, Simon JO.

Pediatrics. 2011 Nov;128(5):e1201-8. doi: 10.1542/peds.2011-0872. Epub 2011 Oct 17.

29.

Treatment of irritable bowel syndrome with comorbid anxiety symptoms with mirtazapine.

Spiegel DR, Kolb R.

Clin Neuropharmacol. 2011 Jan-Feb;34(1):36-8. doi: 10.1097/WNF.0b013e318209cef2. Review.

PMID:
21242743
30.

[Regional coordination of paediatric oncological care in northwestern Lower Saxony, Germany--network funded by health insurance companies].

Müller HL, Blanke JG, Bonse B, Bosse H, Erkel J, Gitmans R, Kolb R, Krull F, Langlitz J, Liebner T, Löning L, Mokross C, Niekrens C, Schüler D, Wessel V, Wosnitza AP.

Klin Padiatr. 2010 Nov;222(6):407-13. doi: 10.1055/s-0030-1265206. Epub 2010 Nov 5. German.

PMID:
21058228
31.

Telomerase immortalization of principal cells from mouse collecting duct.

Steele SL, Wu Y, Kolb RJ, Gooz M, Haycraft CJ, Keyser KT, Guay-Woodford L, Yao H, Bell PD.

Am J Physiol Renal Physiol. 2010 Dec;299(6):F1507-14. doi: 10.1152/ajprenal.00183.2010. Epub 2010 Oct 6.

32.

Microarray profile of gene expression during osteoclast differentiation in modelled microgravity.

Sambandam Y, Blanchard JJ, Daughtridge G, Kolb RJ, Shanmugarajan S, Pandruvada SN, Bateman TA, Reddy SV.

J Cell Biochem. 2010 Dec 1;111(5):1179-87. doi: 10.1002/jcb.22840.

PMID:
20717918
33.

Cosmology forum: Is dark energy really a mystery?

Bianchi E, Rovelli C, Kolb R.

Nature. 2010 Jul 15;466(7304):321-2. doi: 10.1038/466321a. No abstract available.

PMID:
20631785
34.

Protein phosphatase 2A has an essential role in the activation of gamma-irradiation-induced G2/M checkpoint response.

Yan Y, Cao PT, Greer PM, Nagengast ES, Kolb RH, Mumby MC, Cowan KH.

Oncogene. 2010 Jul 29;29(30):4317-29. doi: 10.1038/onc.2010.187. Epub 2010 May 24.

35.

Analyses of treatment variables for patients with childhood craniopharyngioma--results of the multicenter prospective trial KRANIOPHARYNGEOM 2000 after three years of follow-up.

Müller HL, Gebhardt U, Schröder S, Pohl F, Kortmann RD, Faldum A, Zwiener I, Warmuth-Metz M, Pietsch T, Calaminus G, Kolb R, Wiegand C, Sörensen N; study committee of KRANIOPHARYNGEOM 2000/2007.

Horm Res Paediatr. 2010;73(3):175-80. doi: 10.1159/000284358. Epub 2010 Mar 3.

PMID:
20197669
36.

Radical arylation of phenols, phenyl ethers, and furans.

Wetzel A, Pratsch G, Kolb R, Heinrich MR.

Chemistry. 2010 Feb 22;16(8):2547-56. doi: 10.1002/chem.200902927.

PMID:
20066707
37.

Ciliary polycystin-2 is a mechanosensitive calcium channel involved in nitric oxide signaling cascades.

AbouAlaiwi WA, Takahashi M, Mell BR, Jones TJ, Ratnam S, Kolb RJ, Nauli SM.

Circ Res. 2009 Apr 10;104(7):860-9. doi: 10.1161/CIRCRESAHA.108.192765. Epub 2009 Mar 5.

38.

Gamma-irradiation-induced DNA damage checkpoint activation involves feedback regulation between extracellular signal-regulated kinase 1/2 and BRCA1.

Yan Y, Black CP, Cao PT, Haferbier JL, Kolb RH, Spieker RS, Ristow AM, Cowan KH.

Cancer Res. 2008 Jul 1;68(13):5113-21. doi: 10.1158/0008-5472.CAN-07-5818.

39.
40.

First experiences with laparoscopic adjustable gastric banding (LAGB) in the treatment of patients with childhood craniopharyngioma and morbid obesity.

Müller HL, Gebhardt U, Wessel V, Schröder S, Kolb R, Sörensen N, Maroske J, Hanisch E.

Klin Padiatr. 2007 Nov-Dec;219(6):323-5.

PMID:
18050042
41.

Differential expression of CXCL12 and CXCR4 during human fetal neural progenitor cell differentiation.

Peng H, Kolb R, Kennedy JE, Zheng J.

J Neuroimmune Pharmacol. 2007 Sep;2(3):251-8. Epub 2007 Jun 27.

42.

Development of an AT2-deficient proximal tubule cell line for transport studies.

Woost PG, Kolb RJ, Chang CH, Finesilver M, Inagami T, Hopfer U.

In Vitro Cell Dev Biol Anim. 2007 Nov-Dec;43(10):352-60. Epub 2007 Oct 26.

PMID:
17963016
43.

Randomized phase II study of cetuximab plus cisplatin/vinorelbine compared with cisplatin/vinorelbine alone as first-line therapy in EGFR-expressing advanced non-small-cell lung cancer.

Rosell R, Robinet G, Szczesna A, Ramlau R, Constenla M, Mennecier BC, Pfeifer W, O'Byrne KJ, Welte T, Kolb R, Pirker R, Chemaissani A, Perol M, Ranson MR, Ellis PA, Pilz K, Reck M.

Ann Oncol. 2008 Feb;19(2):362-9. Epub 2007 Oct 17.

PMID:
17947225
44.

TAZ promotes PC2 degradation through a SCFbeta-Trcp E3 ligase complex.

Tian Y, Kolb R, Hong JH, Carroll J, Li D, You J, Bronson R, Yaffe MB, Zhou J, Benjamin T.

Mol Cell Biol. 2007 Sep;27(18):6383-95. Epub 2007 Jul 16.

45.

Impact of reduction of therapy on infectious complications in childhood acute lymphoblastic leukemia.

Graubner UB, Porzig S, Jorch N, Kolb R, Wessalowski R, Escherich G, Janka GE.

Pediatr Blood Cancer. 2008 Feb;50(2):259-63.

PMID:
17635005
46.

Alpha-actinin-4 is required for normal podocyte adhesion.

Dandapani SV, Sugimoto H, Matthews BD, Kolb RJ, Sinha S, Gerszten RE, Zhou J, Ingber DE, Kalluri R, Pollak MR.

J Biol Chem. 2007 Jan 5;282(1):467-77. Epub 2006 Nov 2.

47.

Relapse pattern after complete resection and early progression after incomplete resection of childhood craniopharyngioma.

Müller HL, Gebhardt U, Pohl F, Flentje M, Emser A, Warmuth-Metz M, Kolb R, Calaminus G, Sörensen N.

Klin Padiatr. 2006 Nov-Dec;218(6):315-20.

PMID:
17080333
48.

Strategy for the development of a matched set of transport-competent, angiotensin receptor-deficient proximal tubule cell lines.

Woost PG, Kolb RJ, Finesilver M, Mackraj I, Imboden H, Coffman TM, Hopfer U.

In Vitro Cell Dev Biol Anim. 2006 Jul-Aug;42(7):189-200.

PMID:
16948500
49.

Secondary narcolepsy may be a causative factor of increased daytime sleepiness in obese childhood craniopharyngioma patients.

Müller HL, Müller-Stöver S, Gebhardt U, Kolb R, Sörensen N, Handwerker G.

J Pediatr Endocrinol Metab. 2006 Apr;19 Suppl 1:423-9.

PMID:
16700320
50.

Melatonin treatment in obese patients with childhood craniopharyngioma and increased daytime sleepiness.

Müller HL, Handwerker G, Gebhardt U, Faldum A, Emser A, Kolb R, Sörensen N.

Cancer Causes Control. 2006 May;17(4):583-9.

PMID:
16596314

Supplemental Content

Support Center